Literature DB >> 24560955

Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department.

Luis García de Guadiana Romualdo1, Patricia Esteban Torrella2, Monserrat Viqueira González3, Roberto Jiménez Sánchez4, Ana Hernando Holgado2, Alejandro Ortín Freire4, Sergio Rebollo Acebes4, María Dolores Albaladejo Otón2.   

Abstract

BACKGROUND: Bacteremia is indicative of severe bacterial infection with significant mortality. Its early diagnosis is extremely important for implementation of antimicrobial therapy but a diagnostic challenge. Although blood culture is the "gold standard" for diagnosis of bacteremia this method has limited usefulness for the early detection of blood-stream infection. In this study we assessed the presepsin as predictor of bacteremia in patients with systemic inflammatory response syndrome (SIRS) on admission to the Emergency Department and compare it with current available infection biomarkers.
METHODS: A total of 226 patients admitted to the Emergency Department with SIRS were included. In 37 patients blood culture had a positive result (bacteremic SIRS group) and 189 had a negative blood culture result (non-bacteremic SIRS group). Simultaneously with blood culture, presepsin, procalcitonin (PCT) and C-reactive protein (CRP) were measured. Receiver operating characteristic (ROC) curve analysis was performed for each biomarker as predictor of bacteremia.
RESULTS: Presepsin values were significantly higher in bacteremic SIRS group when compared with non-bacteremic SIRS group. ROC curve analysis and area under curve (AUC) revealed a value of 0.750 for presepsin in differentiating SIRS patients with bacteremia from those without, similar than that for PCT (0.787) and higher than that for CRP (0.602). The best cut-off value for presepsin was 729pg/mL, which was associated with a negative predictive value of 94.4%.
CONCLUSION: Presepsin may contribute to rule out the diagnosis of bacteremia in SIRS patients admitted to the Emergency Department.
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteremia; C-reactive protein; Diagnostic accuracy; Emergency Department; Presepsin; Procalcitonin; SIRS

Mesh:

Substances:

Year:  2014        PMID: 24560955     DOI: 10.1016/j.clinbiochem.2014.02.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  23 in total

Review 1.  Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment.

Authors:  Mary Sandquist; Hector R Wong
Journal:  Expert Rev Clin Immunol       Date:  2014-08-21       Impact factor: 4.473

2.  Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).

Authors:  Matej Godnic; David Stubljar; David Stubjar; Miha Skvarc; Tomislav Jukic
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

3.  The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis.

Authors:  Xin Zhang; Dan Liu; You-Ning Liu; Rui Wang; Li-Xin Xie
Journal:  Crit Care       Date:  2015-09-11       Impact factor: 9.097

4.  Determination of reference interval for presepsin, an early marker for sepsis.

Authors:  Davide Giavarina; Mariarosa Carta
Journal:  Biochem Med (Zagreb)       Date:  2015       Impact factor: 2.313

5.  The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis.

Authors:  Zhongjun Zheng; Libing Jiang; Ligang Ye; Yuzhi Gao; Luping Tang; Mao Zhang
Journal:  Ann Intensive Care       Date:  2015-12-08       Impact factor: 6.925

Review 6.  Lysosome and Cytoskeleton Pathways Are Robustly Enriched in the Blood of Septic Patients: A Meta-Analysis of Transcriptomic Data.

Authors:  Jie Ma; Chuanxi Chen; Andreas S Barth; Chris Cheadle; Xiangdong Guan; Li Gao
Journal:  Mediators Inflamm       Date:  2015-04-30       Impact factor: 4.711

7.  Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.

Authors:  Lorenza Pugni; Carlo Pietrasanta; Silvano Milani; Claudia Vener; Andrea Ronchi; Mariella Falbo; Milena Arghittu; Fabio Mosca
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

Review 8.  Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis.

Authors:  Dimitrios Velissaris; Nicholas Zareifopoulos; Vasileios Karamouzos; Evangelos Karanikolas; Charalampos Pierrakos; Ioanna Koniari; Menelaos Karanikolas
Journal:  Cureus       Date:  2021-05-13

9.  Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients.

Authors:  Kada Klouche; Jean Paul Cristol; Julie Devin; Vincent Gilles; Nils Kuster; Romaric Larcher; Laurent Amigues; Philippe Corne; Olivier Jonquet; Anne Marie Dupuy
Journal:  Ann Intensive Care       Date:  2016-07-07       Impact factor: 6.925

Review 10.  Diagnostic Value of Presepsin for Sepsis: A Systematic Review and Meta-Analysis.

Authors:  Jing Zhang; Zhi-De Hu; Jia Song; Jiang Shao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.